Summary
In seeking the putative mechanism of action of diethyldithiocarbamate (DTC) on the immune status of HIV infected patients, the plasma membrane fluidity of peripheral blood lymphocytes (PBL) from DTC-treated and untreated patients (CDC III-IVc1) was determined.
Anisotropy values of the fluorescent probe 6-(9-anthroyloxy) stearic acid were increased in DTC-treated patients (0.175 vs 0.161), indicating decreased PBL plasma membrane fluidity. The membrane rigidifying effect was significantly greater 4 h after i.v. drug administration (0.185 in treated patients).
As the membrane fluidity and the function of membrane embedded antigen are interdependent, it is possible that alterations in biophysical and/or biochemical properties of membranes may account for the beneficial effect of DTC on the immune function and clinical status of HIV infected patients.
This is a preview of subscription content, log in via an institution to check access.
References
Pompidou A, Duchet N, Cooper MD, Mace B, Coutance F, Hadden JW, Renoux G (1985) The generation and regulation of human T lymphocytes by imuthiol. Evidence from an in vitro differentiation induction system. Int J Immunopharmacol 7: 561–566
Renoux G, Renoux M (1980) The effects of sodium diethyldithiocarbamate, azathioprine, cyclophosphamide, or hydrocortisone acetate administered alone or in association for 4 weeks on the immune responses of BALB/c mice. Clin Immunol Immunopathol 15: 23–32
Lang JM, Touraine JL, Trepo C, Choutet P, Kirstetter M, Falkenrodt A, Herviou L, Livrozet JM, Retournaz G, Touraine F, Renoux G, Renoux M, Musset M, Caraux J (1988) Randomised, double-blind, placebo controlled trial of ditiocarb sodium (Imuthiol) in human immunodeficiency virus infection. Lancet i: 702–706
Apostolov K, Barker W, Wood CB, Habib NA, Jeffries D, Forster SM (1987) Fatty acid saturation index in peripheral blood cell membranes of AIDS patients. Lancet i: 695
Ben-Bassat H, Polliak A, Rosenbaum SM, Naparstek E, Shouval D, Inbar M (1977) Fluidity of membrane lipids and lateral mobility of concavalin A receptors in the cell surface of normal lymphocytes and lymphocytes from patients with malignant lymphomas and leukemias. Cancer Res 37: 1307–1312
Puri J, Shinitzky M, Lonai P (1980) Concomittant increase in antigen binding and in T cell membrane lipid viscosity induced by the lymphocyte activating factor, LAF. J Immunol 124: 1937–1942
Ip SHP, Abrahm J, Cooper RA (1980) Enhancement of blastogenesis in cholesterol-enriched lymphocytes. J Immunol 124: 87–93
Hübner C, Lindner SG, Albani M, Keup B, Schürmann M, Stegner H, Claussen M, Kohlschütter A (1989) Increased plasma membrane fluidity and decreased receptor availability of non-muscle cells in myotonic dystrophy. J Neurol Sci 92: 205–214
Thulborn KR (1981) The use ofn-(9-anthroyloxy) fatty acids as fluorescent probes for biomembranes. In: Beddard GS, West MA (eds) Fluorescent probes. Academic Press, London, pp 113–139
Van Blitterswijk WJ, van Hoeven RP, van der Meer BW (1981) Lipid structural order parameters (reciprocal of fluidity) in biomembranes derived from steady-state fluorescence polarization measurements. Biochim Biophys Acta 644: 209–218
Kitagawa S, Endo J, Kametani F (1985) Effects of long-chain cisunsaturated fatty acids and their alcohol analogs on aggregation of bovine platelets and their relation with membrane fluidity changes. Biochim Biophys Acta 818: 391–397
Hübner C, Lindner SG, Stern M, Claussen M, Kohlschütter A (1988) Membrane fluidity and lipid composition of rat small intestinal brush-border membranes during postnatal maturation. Biochim Biophys Acta 939: 145–150
Hilgers J, Van der Slujis PJ, Van Blitterswijk WJ, Emmelot P (1978) Membrane fluidity, capping of cell-surface antigens and immune response in mouse leukaemia cells. Br J Cancer 37: 329–336
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lehr, H.A., Zimmer, J.P., Hübner, C. et al. Decreased plasma membrane fluidity of peripheral blood lymphocytes after diethyldithiocarbamate (DTC) therapy in HIV-infected patients. Eur J Clin Pharmacol 37, 521–523 (1989). https://doi.org/10.1007/BF00558135
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00558135